DiaSys sees growth in Middle East IDD (infectious disease diagnostics) market:
This article was originally published in Clinica
Executive Summary
There is an expanding market for infectious disease diagnostics in the Middle East and Pakistan, driven by World Health Organization initiatives to eradicate major infectious diseases, increasing international travel and immigration, and growing interest in standardisation and accreditation among healthcare authorities. So says DiaSys, the Waterbury, Connecticut test maker that has just signed distribution deals in the region. Distributors in Kuwait, Oman, Bahrain and Pakistan will exclusively promote, sell and service diagnostic products including tools for analysing parasites in human body fluids, urine sediment analysis products and a range of rapid tests for infectious diseases.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.